Skip to main content
. 2024 Jun 6;19:100335. doi: 10.1016/j.xnsj.2024.100335

Table 2.

Associations of baseline characteristics with the LOS for the index hospitalization.

Variable Univariable Models
Multivariable Model 1*
Multivariable Model 2*
(95% CI) p-value (95% CI) p-value (95% CI) p-value
Male sex 20.8 (0.8, 44.7) .041 3.4 (-13.2, 23.2) .71 3.5 (-13.2, 23.4) .70
Age, per 10-year increase -4.8 (-10.1, 0.8) .093 0.5 (-6.0, 7.4) .89 -0.1 (-6.7, 7.0) .98
White race -22.2 (-39.0, -0.9) .042 -15.7 (-32.9, 5.9) .14 -14.2 (-31.8, 7.9) .19
Insurance .006
  Commercial (ref)
  Medicaid 47.8 (12.4, 94.4) 12.1 (-14.9, 47.7) .42 26.0 (-6.4, 69.6) .13
  Medicare 8.3 (-17.6, 42.2) -7.7 (-30.1, 21.8) .57 -1.1 (-25.2, 30.7) .94
  Other 13.4 (-24.7, 70.9) 1.8 (-31.4, 51.0) .93 6.6 (-28.3, 58.3) .75
SSI -43.5 (-53.4, -31.5) <.001 -25.4 (-39.5, -7.9) .007 -26.6 (-41.0, -8.7) .006
Medical comorbidities
  Cirrhosis 42.2 (-4.1, 111.0) .080 1.1 (-30.8, 47.5) .96
  CKD 56.8 (23.1, 99.7) <.001 27.7 (-0.9, 64.4) .058
  DM 16.4 (-5.1, 42.8) .14 7.8 (-12.4, 32.6) .48
  Endocarditis 52.8 (15.5, 102.1) .003 15.4 (-13.0, 53.1) .32
  Chronic SCI/decubitus ulcer 49.8 (11.2, 101.9) .008 41.8 (4.8, 91.7) .024
  HIV 66.5 (-20.6, 249.4) .18 23.3 (-38.6, 147.6) .55
  Malnutrition 101.3 (62.7, 148.9) <.001 64.8 (31.8, 106.1) <.001
  Non-IV drug use 27.2 (-16.8, 94.2) .27 18.8 (-21.0, 78.5) .41
  IVDU 35.1 (10.2, 65.7) .004 6.8 (-19.0, 40.8) .64
Number of comorbidities <.001 <.001
  0 (ref)
  1 49.9 (21.5, 84.9) 29.9 (3.0, 63.7)
  2 82.8 (43.2, 133.5) 54.6 (18.2, 102.1)
  3+ 194.0 (122.1, 289.0) 141.5 (76.7, 229.9)

LOS, length of stay; PSL, primary spoken language; SSI, surgical site infection; CKD, chronic kidney disease; DM, diabetes mellitus; SCI, spinal cord injury; HIV, human immunodeficiency virus; IV, intravenous; IVDU, intravenous drug user.

396 patients without any missing characteristics were included in the multivariable models;

Percent difference in geometric mean of LOS or charges per change in variable.